Blood use in Europe: learning from the impact of COVID-19
This policy briefing, developed by the Blood and Beyond initiative, sheds light on how the COVID-19 pandemic affects blood use, blood transfusion services, and patients in whom transfusions are clinically indicated. The paper provides suggestions to address the challenge and depicts why Europe needs a coordinated vision on the future of blood use more than ever, focusing in particular on the shift to optimized management of the patient’s own blood – a concept known as patient blood management (PBM) and endorsed by the WHO.
The paper was published on May 12, 2021, ahead of the European Commission-Italian G20 Presidency Global Health Summit – set to discuss learnings from the COVID-19 crisis healthcare systems strengthening and multilateral cooperation.
The pandemic underlines the necessity to rethink blood use in Europe and creates additional impetus for reconsidering policy frameworks in place, current clinical practices, education as well as research & data collection efforts; and reveals the potential of alternative, innovative approaches including patient blood management (PBM).